EVLA and Optimal Timing of Sclerotherapy
ConditionVenous Reflux
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorTurku University Hospital
About this trial
The aim of the study is to investigate the optimal timing of sclerotherapy for treatment of varicose tributaries on EVLA (endogenous laser ablation) patients.
Eligibility criteria
Qualifiers
Varicose disease of lower extremity caused by reflux of VSM, SSV or AASV to be treated with EVLA. Age over 18 years. Clinical symptoms C2-3.
Disqualifiers
No severe comorbidities. Previous DVT.
Trial design
Treatments tested in this trial
- Endovenous laser ablation
Treatment groups
350 Participants
are divided into 2 treatment groupsSponsors and collaborators
Turku University Hospital
Lead sponsor
Helsinki University Central Hospital
Collaborator
Oulu University Hospital
Collaborator
Tampere University Hospital
Collaborator
Päijänne Tavastia Central Hospital
Collaborator
Satasairaala
Collaborator
Vaasa Central Hospital, Vaasa, Finland
Collaborator
Source ClinicalTrials.gov